# Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710

> **NCT02756637** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 634 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02756637
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-11
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2023-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02756637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02756637, "Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02756637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*